Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Authors:
Open Access
- 13 July 2023
- journal article
- review article
- Published by Portland Press Ltd. in Neuronal Signaling
- Vol. 7 (2) , NS20220054
Abstract
There are several hypotheses concerning the underlying pathophysiological mechanisms of major depression, which centre largely around adaptive changes in neuronal transmission and plasticity, neurogenesis, and circuit and regional connectivity. The immune and endocrine systems are commonly implicated in driving these changes. An intricate interaction of stress hormones, innate immune cells and the actions of soluble mediators of immunity within the nervous system is described as being associated with the symptoms of depression. Bridging endocrine and immune processes to neurotransmission and signalling within key cortical and limbic brain circuits are critical to understanding depression as a disorder of neuroimmune origins. Emergent areas of research include a growing recognition of the adaptive immune system, advances in neuroimaging techniques and mechanistic insights gained from transgenic animals. Elucidation of glial–neuronal interactions is providing additional avenues into promising areas of research, the development of clinically relevant disease models and the discovery of novel therapies. This narrative review focuses on molecular and cellular mechanisms that are influenced by inflammation and stress. The aim of this review is to provide an overview of our current understanding of depression as a disorder of neuroimmune origin, focusing on neuroendocrine and neuroimmune dysregulation in depression pathophysiology. Advances in current understanding lie in pursuit of relevant biomarkers, as the potential of biomarker signatures to improve clinical outcomes is yet to be fully realised. Further investigations to expand biomarker panels including integration with neuroimaging, utilising individual symptoms to stratify patients into more homogenous subpopulations and targeting the immune system for new treatment approaches will help to address current unmet clinical need.Keywords
Funding Information
- Irish Research Council
This publication has 282 references indexed in Scilit:
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- Childhood Trauma Associated with Short Leukocyte Telomere Length in Posttraumatic Stress DisorderBiological Psychiatry, 2011
- Serum BDNF levels before treatment predict SSRI response in depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeuticsJournal of Cellular Physiology, 2010
- Genetic risk profiles for depression and anxiety in adult and elderly cohortsMolecular Psychiatry, 2010
- Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive BehaviorNeuropsychopharmacology, 2010
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuseNature Neuroscience, 2009
- Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression studyComprehensive Psychiatry, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008